Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial

Sophie Cousin(Institut Bergonié), Antoîne Italiano(Université de Bordeaux)
Clinical Cancer Research
January 25, 2021
Cited by 152


Related Papers